Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2026)

Tarsus Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.94 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 75.8% year-over-year to 0.94; the TTM figure through Mar 2026 stood at 0.94 (up 75.8% YoY), while the FY2025 annual figure was 0.96, up 68.78% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.94, up from 0.82 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.94 in Q1 2026, with the low at 0.06 in Q2 2023.
• The 5-year median for Asset Utilization Ratio is 0.14 (2024), against an average of 0.32.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio plunged 77.06% in 2022, then jumped 643.11% in 2024.
• Tarsus Pharmaceuticals' Asset Utilization Ratio stood at 0.11 in 2022, then slumped by 41.22% to 0.07 in 2023, then surged by 643.11% to 0.49 in 2024, then surged by 69.45% to 0.82 in 2025, then grew by 13.72% to 0.94 in 2026.
• Business Quant data shows TARS's Asset Utilization Ratio at 0.94 in Q1 2026, 0.82 in Q4 2025, and 0.71 in Q3 2025.